AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
HLA class I antigen cell surface expression is preserved on acute myeloid leukemia blasts at diagnosis and at relapse
Authors: Wetzler, M Baer, MR Stewart, SJ Donohue, K Ford, L Stewart, CC Repasky, EA Ferrone, S
Citation: M. Wetzler et al., HLA class I antigen cell surface expression is preserved on acute myeloid leukemia blasts at diagnosis and at relapse, LEUKEMIA, 15(1), 2001, pp. 128-133
Association of HLA class I and class II antigen expression and mortality in uveal melanoma
Authors: Ericsson, C Seregard, S Bartolazzi, A Levitskaya, E Ferrone, S Kiessling, R Larsson, O
Citation: C. Ericsson et al., Association of HLA class I and class II antigen expression and mortality in uveal melanoma, INV OPHTH V, 42(10), 2001, pp. 2153-2156
TAP1 down-regulation in primary melanoma lesions: An independent marker ofpoor prognosis
Authors: Kamarashev, J Ferrone, S Seifert, B Boni, R Nestle, FO Burg, G Dummer, R
Citation: J. Kamarashev et al., TAP1 down-regulation in primary melanoma lesions: An independent marker ofpoor prognosis, INT J CANC, 95(1), 2001, pp. 23-28
Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy
Authors: Ugurel, S Rebmann, V Ferrone, S Tilgen, W Grosse-Wilde, H Reinhold, U
Citation: S. Ugurel et al., Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy, CANCER, 92(2), 2001, pp. 369-376
Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes
Authors: Puppo, F Contini, P Ghio, M Brenci, S Scudeletti, M Filaci, G Ferrone, S Indiveri, F
Citation: F. Puppo et al., Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes, INT IMMUNOL, 12(2), 2000, pp. 195-203
alpha(nu)beta(3) expression on blood vessels and melanoma cells in primarylesions; differential association with tumor progression and clinical prognosis (vol 49, pg 314, 2000)
Authors: Kageshita, T Hamby, CV Hirai, S Kimura, T Ono, T Ferrone, S
Citation: T. Kageshita et al., alpha(nu)beta(3) expression on blood vessels and melanoma cells in primarylesions; differential association with tumor progression and clinical prognosis (vol 49, pg 314, 2000), CANCER IMMU, 49(9), 2000, pp. 515-515
alpha(v)beta(3) expression on blood vessels and melanoma cells in primary lesions; differential association with tumor progression and clinical prognosis
Authors: Kageshita, T Hamby, CV Hirai, S Kimura, T Ono, T Ferrone, S
Citation: T. Kageshita et al., alpha(v)beta(3) expression on blood vessels and melanoma cells in primary lesions; differential association with tumor progression and clinical prognosis, CANCER IMMU, 49(6), 2000, pp. 314-318
HLA-G, -E, -F preworkshop: Tools and protocols for analysis of non-classical class I genes transcription and protein expression
Authors: Paul, P Rouas-Freiss, N Moreau, P Cabestre, FA Menier, C Khalil-Daher, I Pangault, C Onno, M Fauchet, R Martinez-Laso, J Morales, P Villena, AA Giacomini, P Natali, PG Frumento, G Ferrara, GB McMaster, M Fisher, S Schust, D Ferrone, S Dausset, J Geraghty, D Carosella, ED
Citation: P. Paul et al., HLA-G, -E, -F preworkshop: Tools and protocols for analysis of non-classical class I genes transcription and protein expression, HUMAN IMMUN, 61(11), 2000, pp. 1177-1195
Antigen-processing machinery breakdown and tumor growth
Authors: Seliger, B Maeurer, MJ Ferrone, S
Citation: B. Seliger et al., Antigen-processing machinery breakdown and tumor growth, IMMUNOL TOD, 21(9), 2000, pp. 455-464
How much longer will tumour cells fool the immune system?
Authors: Ferrone, S Finerty, JF Jaffee, EM Nabel, GJ
Citation: S. Ferrone et al., How much longer will tumour cells fool the immune system?, IMMUNOL TOD, 21(2), 2000, pp. 70-72
Inmunotherapy of melanoma: Peptide mimics of a human high molecular weight-melanoma associated antigen
Authors: Wang, XH Luo, W Ferrone, S
Citation: Xh. Wang et al., Inmunotherapy of melanoma: Peptide mimics of a human high molecular weight-melanoma associated antigen, MEDICINA, 60, 2000, pp. 48-50
Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta(2)-microglobulin-associated and beta(2)-microglobulin-free HLA class I heavy chains
Authors: Desai, SA Wang, XH Noronha, EJ Zhou, QW Rebmann, V Grosse-Wilde, H Moy, FJ Powers, R Ferrone, S
Citation: Sa. Desai et al., Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta(2)-microglobulin-associated and beta(2)-microglobulin-free HLA class I heavy chains, J IMMUNOL, 165(6), 2000, pp. 3275-3283
Analysis by NMR spectroscopy of the structural homology between the linearand the cyclic peptide recognized by anti-human leukocyte antigen class I monoclonal antibody TP25.99
Authors: Moy, FJ Desai, SA Wang, XH Noronha, EJ Zhou, QW Ferrone, S Powers, R
Citation: Fj. Moy et al., Analysis by NMR spectroscopy of the structural homology between the linearand the cyclic peptide recognized by anti-human leukocyte antigen class I monoclonal antibody TP25.99, J BIOL CHEM, 275(32), 2000, pp. 24679-24685
Differential clinical significance of alpha(v)beta(3) expression in primary lesions of acral lentiginous melanoma and of other melanoma histotypes
Authors: Kageshita, T Hamby, CV Hirai, S Kimura, T Ono, T Ferrone, S
Citation: T. Kageshita et al., Differential clinical significance of alpha(v)beta(3) expression in primary lesions of acral lentiginous melanoma and of other melanoma histotypes, INT J CANC, 89(2), 2000, pp. 153-159
Increased beta 2-microglobulin-free HLA class I heavy chain serum levels in the course of immune responses to viral antigens and to mismatched HLA antigens
Authors: Puppo, F Brenci, S Contini, P Bignardi, D Hamby, CV Filaci, G Ghio, M Scudeletti, M Picciotto, A Indiveri, F Ferrone, S
Citation: F. Puppo et al., Increased beta 2-microglobulin-free HLA class I heavy chain serum levels in the course of immune responses to viral antigens and to mismatched HLA antigens, TISSUE ANTI, 55(4), 2000, pp. 333-341
HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story
Authors: Hicklin, DJ Marincola, FM Ferrone, S
Citation: Dj. Hicklin et al., HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story, MOL MED TOD, 5(4), 1999, pp. 178-186
Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: Relationship to their class I allotype
Authors: Perosa, F Prete, M Luccarelli, G Favoino, B Ferrone, S Dammacco, F
Citation: F. Perosa et al., Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: Relationship to their class I allotype, HUMAN IMMUN, 60(11), 1999, pp. 1058-1066
Molecular mimicry of phage displayed peptides mimicking GD3 ganglioside
Authors: Willers, J Lucchese, A Kanduc, D Ferrone, S
Citation: J. Willers et al., Molecular mimicry of phage displayed peptides mimicking GD3 ganglioside, PEPTIDES, 20(9), 1999, pp. 1021-1026
Where have all the T cells gone? Mechanisms of immune evasion by tumors
Authors: Finke, J Ferrone, S Frey, A Mufson, A Ochoa, A
Citation: J. Finke et al., Where have all the T cells gone? Mechanisms of immune evasion by tumors, IMMUNOL TOD, 20(4), 1999, pp. 158-160
Specific lysis of melanoma cells by receptor grafted T cells is enhanced by anti-idiotypic monoclonal antibodies directed to the scFv domain of the receptor
Authors: Reinhold, U Liu, LD Ludtke-Handjery, HC Heuser, C Hombach, A Wang, XH Tilgen, W Ferrone, S Abken, H
Citation: U. Reinhold et al., Specific lysis of melanoma cells by receptor grafted T cells is enhanced by anti-idiotypic monoclonal antibodies directed to the scFv domain of the receptor, J INVES DER, 112(5), 1999, pp. 744-750
Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells
Authors: Wang, ZG Marincola, FM Rivoltini, L Parmiani, G Ferrone, S
Citation: Zg. Wang et al., Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells, J EXP MED, 190(2), 1999, pp. 205-215
Natural variation of the expression of HLA and endogenous antigen modulates ctl recognition in an in vitro melanoma model
Authors: Cormier, JN Panelli, MC Hackett, JA Bettinotti, MP Mixon, A Wunderlich, J Parker, LL Restifo, NP Ferrone, S Marincola, FM
Citation: Jn. Cormier et al., Natural variation of the expression of HLA and endogenous antigen modulates ctl recognition in an in vitro melanoma model, INT J CANC, 80(5), 1999, pp. 781-790
Increased serum levels of beta 2m-free HLA class I heavy chain in multiplemyeloma
Authors: Perosa, F Luccarelli, G Prete, M Ferrone, S Dammacco, F
Citation: F. Perosa et al., Increased serum levels of beta 2m-free HLA class I heavy chain in multiplemyeloma, BR J HAEM, 106(4), 1999, pp. 987-994
Down-regulation of HLA class I antigen-processing molecules in malignant melanoma - Association with disease progression
Authors: Kageshita, T Hirai, S Ono, T Hicklin, DJ Ferrone, S
Citation: T. Kageshita et al., Down-regulation of HLA class I antigen-processing molecules in malignant melanoma - Association with disease progression, AM J PATH, 154(3), 1999, pp. 745-754
beta(2)-mu-free HLA class I heavy chain levels in sera of healthy individuals. Lack of association with beta(2)-mu-associated HLA class I heavy chainlevels and HLA phenotype
Authors: Puppo, F Bignardi, D Contini, P Brenci, S Lanza, L Ghio, M Scudeletti, M Indiveri, F Ferrone, S
Citation: F. Puppo et al., beta(2)-mu-free HLA class I heavy chain levels in sera of healthy individuals. Lack of association with beta(2)-mu-associated HLA class I heavy chainlevels and HLA phenotype, TISSUE ANTI, 53(3), 1999, pp. 253-262
Risultati: 1-25 | 26-28